ALX Oncology Holdings Inc valuation and forecast
Explore the models for ALX Oncology Holdings Inc, adjust their assumptions and compare your own valuation with the platform's.
Stock price today
Loading chart…
Third-party market data · may be delayed
Fair value per share
Under review: data-quality checks not passed.
Price vs value
Under review: data-quality checks not passed. We'll show the comparison once resolved.
Analyst recommendations
Monthly trend
- Oct 20267
- Sep 20267
Counts of recommendations published by analysts covering ALX Oncology Holdings Inc, by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.
Price history
Loading chart…
Third-party market data · may be delayed
ALXO valuation questions
- How does Fundamentalytics value ALX Oncology Holdings Inc?
- We use the models that fit ALX Oncology Holdings Inc's business and available financial data. Each model has its own assumptions and data requirements. The calculator explains which models are available and lets you adjust their inputs.
Data: SEC EDGAR filings, retrieved November 1, 2026. Method: how we value companies. Disclosures: research and recommendations disclosure. Back to ALX Oncology Holdings Inc.